Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**QuikHEAL** is a topical veterinary skin ointment marketed for horses. It is a **combination antimicrobial formulation** containing **sulfur** and **copper sulfate**, used as a broad-spectrum **antibacterial and antifungal** treatment for greasy heel and other equine skin conditions such as rain scald, ringworm, dermatitis, girth gall, saddle sores, and minor cuts. Its reported activity is based on creating an unfavorable environment for microbial growth while acting as a water-resistant protective barrier over affected skin. The product is associated with **Kelato Animal Health** and is manufactured in a GMP-approved facility. It is not a human pharmaceutical drug and appears to be a branded veterinary topical product rather than a single defined molecular entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on QuikHEAL.